08-Sep-2010 - Actavis is looking to enter the biosimilars sector through the proposed acquisition of a stake in Biopartners.
07-Sep-2010 - Indian drugmaker Cipla may invest in South Africa’s Cipla Medpro to boost manufacturing capacity and improve access to rapidly expanding African pharmaceutical markets.
06-Sep-2010 - Colorcon says proximity to emerging drug manufacturing markets was key driver for new Turkey technical service lab.
01-Sep-2010 - NanGenex is introducing GMP bench-top and pilot plant reactors to scale-up its process for the continuous production of nanostructured active ingredients.
31-Aug-2010 - Genzyme has rejected Sanofi-Aventis' $18.5bn (€14.5bn) takeover bid, describing it as offering no improvement in price on the previous proposal and failing “to establish a basis for engagement.”
31-Aug-2010 - Laboratory study shows succinyl-chitosan extended-release (XR) excipient could outperform commercially-available delivery technologies, says Spenser Pharmaceuticals.
26-Aug-2010 - Transdermal delivery of a broader range of therapeutics could be possible using microdevice fabrication technology Vyteris inked a deal to access.
19-Aug-2010 - Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.
16-Aug-2010 - Scolr Pharma reduces losses despite drop in revenue by cutting spending on product R&D and operations.
11-Aug-2010 - Elan puts plans to sell EDT delivery division on hold because market is not “conducive to an appropriate valuation.”
09-Aug-2010 - Respiratory formulations specialist Vectura has licensed two dry-formulation technologies to GSK, further strengthening its position in the $25bn (€19bn) asthma and COPD market.
09-Aug-2010 - A Johnson & Johnson (J&J) unit has licensed a gastric retentive drug delivery technology from Depomed for use in a combination therapy.
05-Aug-2010 - Penwest Pharmaceuticals raises guidance citing Opana ER royalties, deals and patent settlements as Q2 highlights; but warns that job cuts likely under cost cutting plan.
04-Aug-2010 - In the first of a series of special in-pharmatechnologist podcasts Kate Wilber, Image Solutions’ (ISI) director of regulatory Services, Europe discusses the emerging trends in BPO and talks about how...
03-Aug-2010 - FDA draft guidance published this week recommends manufacturers of drug delivery patches adopt QbD to minimise the amount of excess residual drug.
28-Jul-2010 - Mylan hopes new solid-dose packaging plant in Hungary will help it increase market share in Eastern Europe.
20-Jul-2010 - A group of Irish drug firms and banks plan to set up a “global pharmaceutical centre of excellence” (COE) that they believe will create 4,800 research, development and manufacturing jobs.
19-Jul-2010 - Germany’s Merck KGaA has completed its $7bn (€b5.2n) acquisition of Millipore, unveiling plans to target “high-growth, high-margin” bio-research and bio-production markets.
15-Jul-2010 - Encap has announced its DuoCap capsule delivery system has been granted US and European patents that strengthen the firm’s portfolio in the delivery of pharmaceutical active agents that require controlled...
08-Jul-2010 - Brazilian generics manufacturer Eurofarma has acquired Uruguay counterpart Laboratorios Gautier, further expanding its reach across Latin America.
06-Jul-2010 - Chemicals manufacturer BASF reorganises Swiss business to cut active pharmaceutical ingredient (API) manufacturing site complexity and simplify process operations.
24-Jun-2010 - US drugmaker Merck & Co’s new deal with Adcock Ingram proves the FIFA football World Cup isn’t the only thing attracting people to South Africa this summer.
10-Jun-2010 - MonoSol Rx and Applied Pharma Research have agreed to expand their working partnership to produce and market current prescription drug products in film form. This method of drug delivery has...
02-Jun-2010 - Indian API manufacturer Shasun Chemicals and Drugs turned a previous loss into profit for Q4 of this year as it seeks to make a dent in the biosimilar manufacturing sector.
01-Jun-2010 - Irish pharmaceutical company Elan says most potential investors are positive about proposal to spin-off drug delivery unit.